#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2188784	A	Half life in human serum at 40 mM by HPLC	Homo sapiens	6		cell-free format	Scientific Literature
2.	ALA2188788	F	Agonist activity at turkey P2Y1R expressed in 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry	Meleagris gallopavo	7		cell-based format	Scientific Literature
3.	ALA2188792	P	Half life in Tris buffer at pH 9.8 at 0.2 mg by HPLC in presence of alkaline phosphatase		6		small-molecule physicochemical format	Scientific Literature
4.	ALA2182177	A	Stability of the compound assessed as human eNPP1-mediated degradation of compound measuring increase in NMP level at pH 8.5 at 0.2 mM after 20 mins by HPLC relative to control	Homo sapiens	6		single protein format	Scientific Literature
5.	ALA2182180	F	Antiplatelet activity in Balb/c mouse assessed as inhibition of ADP-induced aggregation measuring prolongation of bleeding time at 30 mg/kg body weight, iv	Mus musculus	2		organism-based format	Scientific Literature
6.	ALA2182181	F	Antidiabetic activity in db+/db- diabetic mouse model assessed as reduction in blood glucose level at 30 mg/kg body weight, iv administered 10 min post glucose challenge measured over 15 to 120 mins	Mus musculus	1		organism-based format	Scientific Literature
7.	ALA2182182	F	Antagonist activity at human P2Y12R expressed in U-205 cells assessed as intracellular calcium level in presence of ADP	Homo sapiens	1		cell-based format	Scientific Literature
8.	ALA2182183	F	Antiplatelet activity in Lewis rat assessed as inhibition of ADP-induced aggregation measuring prolongation in bleeding time at 30 mg/kg body weight, po administered 30 mins prior to tail incision measured after 5 mins	Rattus norvegicus	1		organism-based format	Scientific Literature
9.	ALA2182184	F	Antiplatelet activity in Balb/c mouse assessed as inhibition of ADP-induced aggregation measuring prolongation in bleeding time at 30 mg/kg body weight, iv administered prior to tail incision measured after 5 mins relative to active clopidogrel metabolite R-361015	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA2182185	F	Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation at 0.3 to 10 uM measured after 6 mins by aggregometry relative to control	Homo sapiens	1		cell-free format	Scientific Literature
11.	ALA2182186	F	Antiplatelet activity in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation measured after 6 mins by aggregometry	Homo sapiens	1		cell-free format	Scientific Literature
12.	ALA2182187	F	Antidiabetic activity in STZ treated fasted ICR mouse assessed as reduction in blood glucose level at 30 mg/kg body weight, iv administered 10 min post glucose challenge measured over 15 to 120 mins	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA2182190	F	Antidiabetic activity in overnight fasted Wister Han rat assessed as reduction in blood glucose level at 30 mg/kg body weight, iv administered 10 mins post glucose challenge measured within 45 mins (Rvb = 155 mg/dl)	Rattus norvegicus	1		organism-based format	Scientific Literature